Skip to content
Home/Companies/Biotech/SignaCor
SignaCor

SignaCor

Biotech·UK·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns SignaCor?

SignaCor is a British Biotech company, currently owned by Qubis since 2024.

Hand-verified · updated 2026-07-08

Open JSON · CC-BY
Qubis
Investor
Qubis
QUBIS Ltd · 1984 · Evergreen

Key facts

HQUK
SectorBiotech
StatusActive
Websitesignacor.co.uk

More from QUBIS Ltd

Other portfolio companies in the same fund.

Respiratory Analytics Ltd (aflo)
Active
MedTechDerry/Londonderry, Northern Ireland, United Kingdom· 2026
InnovaScope
Active
MedTechUK· 2025
LoyalBe
LoyalBe
Active
FintechUK· 2025
ReNewVax
Active
BiotechUK· 2025
Retinize
Active
Deep TechUK· 2025
StimOxyGen
StimOxyGen
Active
BiotechUK· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns SignaCor?

SignaCor is currently owned by Qubis, through QUBIS Ltd, since 2024.

When did Qubis acquire SignaCor?

Qubis acquired SignaCor in 2024.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue